Nishadil
Signup Signin
Delhi | 25°C (windy)
Unpacking Newron's Q4 2023: A Closer Look at Evenamide's Journey and Financial Health

Unpacking Newron's Q4 2023: A Closer Look at Evenamide's Journey and Financial Health
Anavex's European Dream for Blarcamesine Hits a Regulatory Wall

Anavex's European Dream for Blarcamesine Hits a Regulatory Wall
A Glimmer of Hope: Blarcamesine's Enduring Promise for Rett Syndrome

A Glimmer of Hope: Blarcamesine's Enduring Promise for Rett Syndrome
Taysha Gene Therapies' TSHA-102 Receives FDA Breakthrough Status: A New Hope for Rett Syndrome

Taysha Gene Therapies' TSHA-102 Receives FDA Breakthrough Status: A New Hope for Rett Syndrome
Anavex Life Sciences Unveils Landmark Publication: Blarcamesine Heralds a New Era in Neurological Treatment

Anavex Life Sciences Unveils Landmark Publication: Blarcamesine Heralds a New Era in Neurological Treatment
Load more..